The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Clinical trial NCT06027567 · COMPLETED

Trial details

NCT number: NCT06027567
Sponsor: Rigmor Højland Jensen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Idiopathic Intracranial Hypertension Intracranial Pressure Obesity Pseudotumor Cerebri Syndrome Papilledema Weight Loss

Start date: 2022-09-02
Primary completion: 2025-01-28
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.